Paroxysmal Nocturnal Hemoglobinuria Treatment and Forecast Market

List of Tables
Table 1. Paroxysmal Nocturnal Hemoglobinuria Treatment Market Opportunities & Trends in Global Market
Table 2. Paroxysmal Nocturnal Hemoglobinuria Treatment Market Drivers in Global Market
Table 3. Paroxysmal Nocturnal Hemoglobinuria Treatment Market Restraints in Global Market
Table 4. Key Players of Paroxysmal Nocturnal Hemoglobinuria Treatment in Global Market
Table 5. Top Paroxysmal Nocturnal Hemoglobinuria Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Paroxysmal Nocturnal Hemoglobinuria Treatment Product Type
Table 9. List of Global Tier 1 Paroxysmal Nocturnal Hemoglobinuria Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Paroxysmal Nocturnal Hemoglobinuria Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Achillion Pharmaceuticals Inc Corporate Summary
Table 31. Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Product Offerings
Table 32. Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Akari Therapeutics Plc Corporate Summary
Table 34. Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Treatment Product Offerings
Table 35. Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Alexion Pharmaceuticals Inc Corporate Summary
Table 37. Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Product Offerings
Table 38. Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Alnylam Pharmaceuticals Inc Corporate Summary
Table 40. Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Product Offerings
Table 41. Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Amgen Inc Corporate Summary
Table 43. Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Product Offerings
Table 44. Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Apellis Pharmaceuticals Inc Corporate Summary
Table 46. Apellis Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Product Offerings
Table 47. Apellis Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue (US$, Mn), (2017-2022)
Table 48. F. Hoffmann-La Roche Ltd Corporate Summary
Table 49. F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Product Offerings
Table 50. F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue (US$, Mn), (2017-2022)
Table 51. ISU ABXIS Co Ltd Corporate Summary
Table 52. ISU ABXIS Co Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Product Offerings
Table 53. ISU ABXIS Co Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Novartis AG Corporate Summary
Table 55. Novartis AG Paroxysmal Nocturnal Hemoglobinuria Treatment Product Offerings
Table 56. Novartis AG Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue (US$, Mn), (2017-2022)
Table 57. NovelMed Therapeutics Inc Corporate Summary
Table 58. NovelMed Therapeutics Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Product Offerings
Table 59. NovelMed Therapeutics Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue (US$, Mn), (2017-2022)
Table 60. Omeros Corp Corporate Summary
Table 61. Omeros Corp Paroxysmal Nocturnal Hemoglobinuria Treatment Product Offerings
Table 62. Omeros Corp Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue (US$, Mn), (2017-2022)
Table 63. Ra Pharmaceuticals Inc Corporate Summary
Table 64. Ra Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Product Offerings
Table 65. Ra Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue (US$, Mn), (2017-2022)
Table 66. Regeneron Pharmaceuticals Inc Corporate Summary
Table 67. Regeneron Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Product Offerings
Table 68. Regeneron Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue (US$, Mn), (2017-2022)
Table 69. Regenesance BV Corporate Summary
Table 70. Regenesance BV Paroxysmal Nocturnal Hemoglobinuria Treatment Product Offerings
Table 71. Regenesance BV Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Paroxysmal Nocturnal Hemoglobinuria Treatment Segment by Type in 2021
Figure 2. Paroxysmal Nocturnal Hemoglobinuria Treatment Segment by Application in 2021
Figure 3. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue in 2021
Figure 8. By Type - Global Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share, 2017-2028
Figure 12. US Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share, 2017-2028
Figure 24. China Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Apellis Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. ISU ABXIS Co Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Novartis AG Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. NovelMed Therapeutics Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Omeros Corp Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Ra Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Regeneron Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Regenesance BV Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)